Source: Eur Respir J, 50 (1) 1700004; 10.1183/13993003.00004-2017
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Tolu Oni, Natacha Berkowitz, Mmamapudi Kubjane, Rene Goliath, Naomi S. Levitt, Robert J. Wilkinson. Trilateral overlap of tuberculosis, diabetes and HIV-1 in a high-burden African setting: implications for TB control. Eur Respir J, 50 (1) 1700004; 10.1183/13993003.00004-2017

Member's Comments

No comment yet.

Related content which might interest you: The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results Source: Eur Respir J 2011; 38: 1374-1381 Year: 2011 TB drug resistance in high-incidence countries Source: Eur Respir Mon 2012; 58: 95-110 Year: 2012 Prevalence of urban vs rural HIV infection in patients of pulmonary tuberculosis: An Indian scenario Source: Annual Congress 2010 - Clinical tuberculosis Year: 2010 Pre-immigration screening process and pulmonary tuberculosis among Ethiopian migrants in Israel Source: Eur Respir J 2008; 32: 413-418 Year: 2008 Addressing the tuberculosis (TB) and diabetes mellitus (DM) co-epidemic among TB patients in Luanda, Angola Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease Year: 2016 Tuberculosis screening of migrants to low-burden nations: insights from evaluation of UK practice Source: Eur Respir J 2011; 37: 1175-1182 Year: 2011 Active tuberculosis cases in migrants in Newham: should we extend screening criteria for latent tuberculosis infection Source: International Congress 2017 – Migrants and screening Year: 2017 Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia) Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection Source: Eur Respir J 2010; 36: 1242-1247 Year: 2010 The risk factors of latent tuberculosis infection among health care workers in South Korea, an intermediate tuberculosis burden country Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity Year: 2018 The incidence of MDR-TB in new and retreatment cases of HIV and pulmonary tuberculosis co-infection Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013 High prevalence of hepatitis C among patients with drug-resistant tuberculosis and its impact on the treatment outcome in Azerbaijan prisons Source: International Congress 2015 – Screening strategies in TB Year: 2015 Estimating the prevalence of latent tuberculosis in a low-incidence setting: Australia Source: Eur Respir J, 52 (6) 1801218; 10.1183/13993003.01218-2018 Year: 2018 Assessing the risk of tuberculosis infection in a vulnerable population group (ethnicity rrome) in a TB endemic population Source: Annual Congress 2011 - Tuberculosis epidemiology and public health Year: 2011 HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Incidence of TB latent infection in health care workers in a low TB prevalence country Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI Year: 2005 Treatment of latent tuberculosis in immigrants from Somalia: Case-monitoring and adherence Source: Annual Congress 2010 - Tuberculosis in special populations Year: 2010 MDR-TB treatment outcomes in HIV positive patients Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Prevention of TB in areas of low incidence Source: Eur Respir Mon 2012; 58: 72-83 Year: 2012